Macrogen, Inc. (KOSDAQ:038290)

South Korea flag South Korea · Delayed Price · Currency is KRW
17,270
+280 (1.65%)
At close: Jan 29, 2026
5.50%
Market Cap187.23B
Revenue (ttm)179.98B +36.6%
Net Income-700.38M
EPS-65.98
Shares Out10.84M
PE Ration/a
Forward PE24.02
Dividend300.00 (1.77%)
Ex-Dividend DateDec 29, 2025
Volume46,143
Average Volume40,946
Open16,960
Previous Close16,990
Day's Range16,550 - 17,320
52-Week Range14,720 - 19,460
Beta0.70
RSI59.99
Earnings DateFeb 13, 2026

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 475
Stock Exchange KOSDAQ
Ticker Symbol 038290
Full Company Profile

Financial Performance

In 2024, Macrogen's revenue was 135.78 billion, an increase of 2.24% compared to the previous year's 132.80 billion. Losses were -7.60 billion, -54.78% less than in 2023.

Financial Statements